4.6 Article

Risk factors for coagulopathy after Liver resection

期刊

JOURNAL OF CLINICAL ANESTHESIA
卷 26, 期 8, 页码 654-662

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jclinane.2014.08.002

关键词

Epidural anesthesia; Liver resection; Coagulopathy; Risk factors

向作者/读者索取更多资源

Study Objective: To identify risk factors for coagulopathy in patients undergoing liver resection. Design: A retrospective cohort study. Setting: Patients who underwent liver resection at a university hospital between April 2010 and May 2011 were evaluated within seven days after surgery. Patients: One hundred forty-seven patients were assessed for eligibility. Thirty needed to be excluded because of incomplete data (23) or a preexisting coagulopathy (7). Measurements: Coagulopathy was defined as 1 or more of the following events: international normalized ratio >= 1.4, platelet count <80,000/mu L, and partial thromboplastin time >38 seconds. Related to the time course and coagulation profile thresholds, 3 different groups could be distinguished: no coagulopathy, temporary coagulopathy, and persistent coagulopathy. Main Results: Seventy-seven patients (65.8%) had no coagulopathy, whereas 33 (28.2%) developed temporary coagulopathy and 7(6%) developed persistent coagulopathy until day 7. Preoperative international normalized ratio (P = .001), postoperative peak lactate levels (P = .012), and resected liver weight (P = .005) were identified as independent predictors. Preoperative liver transaminases and transfusion volumes of red blood cells and fresh frozen plasma were significantly higher in patients with persistent coagulopathy. Conclusions: Epidural anesthesia is feasible in patients scheduled for liver resection. Caution should be observed for patients with extended resection 3 segments) and increased postoperative lactate. In patients with preexisting liver disease, epidural catheters should be avoided. (C) 2014 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据